Cost-effectiveness analysis of venetoclax plus azacitidine for naive acute myeloid leukemia

ZHOU Jie, LIU Mengying, WANG Siliang, YANG Yonggong, ZHANG Jinping

Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (19) : 2261-2267.

PDF(1139 KB)
PDF(1139 KB)
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (19) : 2261-2267. DOI: 10.13286/j.1001-5213.2024.19.10
Drug and Clinical

Cost-effectiveness analysis of venetoclax plus azacitidine for naive acute myeloid leukemia

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(19): 2261-2267 https://doi.org/10.13286/j.1001-5213.2024.19.10

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1139 KB)

Accesses

Citation

Detail
Sections
Recommended
Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat

/

〈 〉